Andrew Guirguis

9PUBLICATIONS

83CO-AUTHORS

Nanoscale characterisationMolecular targetsProcess control and simulationCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 21, 2026

SUMOylation enhances DNMT1 function to repress mega-intergenic RNAs and viral mimicry.

|Aug 07, 2023

Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity.

Andrew A Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic

|Sep 20, 2022

Systematic profiling of conditional degron tag technologies for target validation studies.

Daniel P Bondeson, Zachary Mullin-Bernstein, Sydney Oliver

|Dec 09, 2021

Non-genetic determinants of malignant clonal fitness at single-cell resolution.

Katie A Fennell, Dane Vassiliadis, Enid Y N Lam

|Dec 04, 2021

Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death.

Sylvain Garciaz, Andrew A Guirguis, Sebastian Müller

|May 24, 2021

Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.

Aline Renneville, Jessica A Gasser, Daniel E Grinshpun

Pageof 2

Frequent Collaborators

Mark A Dawson

Enid Y N Lam

Sarah-Jane Dawson

Yih-Chih Chan

Sebastian Hollizeck

Dane Vassiliadis

Mikołaj Słabicki

Brian Liddicoat

Benjamin L Ebert

Eric S Fischer

Frequent Collaborators

Mark A Dawson

Enid Y N Lam

Sarah-Jane Dawson

Yih-Chih Chan